Search research articles
Contact Us
Filters
Showing results (31-40 of 115) with videos related to
Page
of 12
Sort By:
AJR. American Journal of Roentgenology
|
June 30, 2021
CAR T-Cell Therapy: An Update for Radiologists
Justin G Yoon, Daniel A Smith, Sree H Tirumani, et al.
Cancer Chemotherapy and Pharmacology
|
November 5, 2022
Exposure-response analysis of Camidanlumab tesirine in patients with relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma
Marie Toukam, Joseph P Boni, Mehdi Hamadani, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
March 9, 2017
Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant
Masumi Ueda, Carlos Silva, Linda Baer, et al.
JAMA Dermatology
|
April 23, 2015
Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients: A Systematic Review
Jennifer L DePry, Ritva Vyas, Hillard M Lazarus, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 6, 2022
Matching-adjusted Indirect Comparison of the Efficacy of Loncastuximab Tesirine Versus Treatment in the Chemoimmunotherapy Era for Relapsed/Refractory Diffuse Large B-cell Lymphoma
Mehdi Hamadani, Lei Chen, Yan Song, et al.
Hematological Oncology
|
June 1, 2022
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclines
Akiva Diamond, Sabarish Ayyappan, Shufen Cao, et al.
Oncology Nursing Forum
|
October 19, 2019
Factors Influencing Patients' Intention to Perform Physical Activity During Hematopoietic Cell Transplantation
Samantha Kolke, Megan Kuhlenschmidt, Erica Bauer, et al.
Blood Advances
|
August 16, 2020
CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy
Bicky Thapa, Paolo F Caimi, Kirit M Ardeshna, et al.
Journal of Computer Assisted Tomography
|
June 20, 2020
Clinical, Imaging Findings, Responses, and Outcomes of Patients With Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma Undergoing Immune Checkpoint Inhibitor Therapy: A Single-Institution Experience
Joseph Liput, Ezgi Guler, Daniel A Smith, et al.
Cancer Chemotherapy and Pharmacology
|
November 5, 2022
Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma
Marie Toukam, Jens Wuerthner, Karin Havenith, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 115) with videos related to
Sort By:
Page
of 12
AJR. American Journal of Roentgenology
|
June 30, 2021
CAR T-Cell Therapy: An Update for Radiologists
Justin G Yoon, Daniel A Smith, Sree H Tirumani, et al.
Cancer Chemotherapy and Pharmacology
|
November 5, 2022
Exposure-response analysis of Camidanlumab tesirine in patients with relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma
Marie Toukam, Joseph P Boni, Mehdi Hamadani, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
March 9, 2017
Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant
Masumi Ueda, Carlos Silva, Linda Baer, et al.
JAMA Dermatology
|
April 23, 2015
Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients: A Systematic Review
Jennifer L DePry, Ritva Vyas, Hillard M Lazarus, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 6, 2022
Matching-adjusted Indirect Comparison of the Efficacy of Loncastuximab Tesirine Versus Treatment in the Chemoimmunotherapy Era for Relapsed/Refractory Diffuse Large B-cell Lymphoma
Mehdi Hamadani, Lei Chen, Yan Song, et al.
Hematological Oncology
|
June 1, 2022
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclines
Akiva Diamond, Sabarish Ayyappan, Shufen Cao, et al.
Oncology Nursing Forum
|
October 19, 2019
Factors Influencing Patients' Intention to Perform Physical Activity During Hematopoietic Cell Transplantation
Samantha Kolke, Megan Kuhlenschmidt, Erica Bauer, et al.
Blood Advances
|
August 16, 2020
CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy
Bicky Thapa, Paolo F Caimi, Kirit M Ardeshna, et al.
Journal of Computer Assisted Tomography
|
June 20, 2020
Clinical, Imaging Findings, Responses, and Outcomes of Patients With Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma Undergoing Immune Checkpoint Inhibitor Therapy: A Single-Institution Experience
Joseph Liput, Ezgi Guler, Daniel A Smith, et al.
Cancer Chemotherapy and Pharmacology
|
November 5, 2022
Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma
Marie Toukam, Jens Wuerthner, Karin Havenith, et al.
Page
of 12